REDCap

The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit U.S. phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

GJby3EXarqSVT3icI7MW8o7RbKzSEk9W2xibptW89nwa7vUwmYujT7ptr9zauqx2C

Rasch-built Outcome Measures to Improve ALS Clinical Trials

What is the Purpose of the study?

The goal of this study is to develop and validate better scales for tracking ALS progression with the hopes that these tools can lead to faster, more efficient, and more decisive ALS clinical trials in the future.

Who is eligible?

We are recruiting adults with a diagnosis of ALS (or ALS variants including PLS and PMA) anywhere in the United States to participate in this fully remote study.

What is required?

Study participants will complete questionnaires on the computer about their ALS (the ROADS and the ALSFRS-R) every month for a minimum of 6 months. Participants will also complete questionnaires 1 time by phone. Participants will also have a minimum of 2 neurologic exams by video teleconference to validate a new telemedicine neurologic exam scale. No in-person visits are required. This study is not expected to benefit participants directly, but we hope this research will allow us to conduct more effective ALS research studies in the future.

This survey is not closed to enrollment. Thank you for your time

Emmory ALS Center